Diabetes & Endocrinology
Global

Diabetes & Endocrinology Experts

Tuyen Truong

Non-Executive Chairman
life sciencess
ECLA Estudios Cl?nicos Latinoam?rica
Costa Rica

Biography

 entific Affairs with Pharmasset. From 2002 until its acquisition by Gilead Sciences (Nasdaq: GILD) for $11 billion in 2012, he was responsible for licensing, strategic transactions, and alliance management of collaborations and partnerships with pharmaceutical companies and universities. He provided business and scientific leadership to drug development programs for the treatment of HIV, Hepatitis B and Hepatitis C, including Sofosbuvir. Prior to Pharmasset, Dr. De La Rosa held both scientific and business positions at Visible Genetics, where he was responsible for the deve

Research Interest

 entific Affairs with Pharmasset. From 2002 until its acquisition by Gilead Sciences (Nasdaq: GILD) for $11 billion in 2012, he was responsible for licensing, strategic transactions, and alliance management of collaborations and partnerships with pharmaceutical companies and universities. He provided business and scientific leadership to drug development programs for the treatment of HIV, Hepatitis B and Hepatitis C, including Sofosbuvir. Prior to Pharmasset, Dr. De La Rosa held both scientific and business positions at Visible Genetics, where he was responsible for the deve

Global Experts from Costa Rica

Global Experts in Subject

Share This Profile
Recommended Conferences
  • Annual Congress on Research and Innovations in Medicine July 02-03, 2018 Bangkok, Thailand

    July 02-03, 2018 Bangkok, Thailand

  • International Conference on Medical and Health Science August 24-25, 2018 Tokyo, JAPAN

    August 24-25, 2018 Tokyo, Japan

  • International Conference on Clinical Gastroenterology and Hepatology

    August 29-30, 2018 Toronto, Canada

View more